A-Z of Research, Innovation, Emerging Therapies & Future Direction Terms

​

Artificial Intelligence (AI) in Oncology

Artificial Intelligence (AI) in oncology refers to the use of advanced computer systems and machine learning technologies to support cancer diagnosis, treatment planning, research, and patient education. In pediatric oncology, AI has the potential to improve access to information, assist with data analysis, identify treatment patterns, and support healthcare decision-making. Emerging tools such as Wilms Tumor AI (WTAI) represent new opportunities to make trusted childhood cancer information more accessible to families and healthcare professionals.

 

Biomarker

A biomarker is a measurable biological characteristic that provides information about a disease or treatment response. Biomarkers may include genes, proteins, molecules, or other biological indicators that help researchers understand cancer behavior. In Wilms tumor research, biomarkers are increasingly being studied to improve diagnosis, risk stratification, treatment selection, and long-term outcome prediction.

 

Cancer Registry

A cancer registry is a database that collects information about cancer diagnoses, treatments, outcomes, and survival. Cancer registries play an important role in public health, research, epidemiology, and healthcare planning. Information gathered through childhood cancer registries helps researchers better understand Wilms tumor incidence, treatment effectiveness, survivorship trends, and global disease patterns.

 

Clinical Research

Clinical research involves studies designed to improve understanding of diseases, treatments, patient outcomes, and healthcare practices. Clinical research plays a vital role in advancing Wilms tumor care and has contributed significantly to the dramatic improvements in survival achieved over recent decades. Ongoing research continues to explore new therapies, risk factors, and survivorship issues.

 

Data Sharing

Data sharing refers to the exchange of research findings, patient data, treatment outcomes, and scientific information between researchers and healthcare organizations. Responsible data sharing accelerates scientific discovery, strengthens collaboration, and helps improve outcomes for children with cancer. International collaboration is particularly important in rare diseases such as Wilms tumor.

 

Epidemiology Research

Epidemiology research examines how diseases occur and affect populations. In Wilms tumor, epidemiological studies help researchers understand incidence rates, geographic variations, survival outcomes, genetic influences, and healthcare disparities. This information supports policy development, research planning, and improved patient care.

 

Evidence-Based Practice

Evidence-based practice involves making healthcare decisions based on the best available scientific evidence combined with clinical expertise and patient needs. Evidence-based approaches help ensure that children with Wilms tumor receive treatments and supportive care that have been proven to be safe and effective through research and clinical experience.

 

Experimental Therapy

Experimental therapy refers to treatments that are still being investigated and have not yet become part of standard medical practice. Experimental therapies may be evaluated through clinical trials and research studies. These approaches offer opportunities to explore new ways of treating high-risk, recurrent, or treatment-resistant Wilms tumor.

 

Gene Expression

Gene expression describes the process by which genetic information is used to produce proteins and regulate biological functions. Researchers study gene expression patterns in Wilms tumor to better understand tumor biology, identify potential treatment targets, and improve risk classification. Advances in gene expression analysis continue to enhance childhood cancer research.

 

Genetic Mutation

A genetic mutation is a change in DNA that may affect how cells function. Some genetic mutations are associated with an increased risk of developing Wilms tumor or may influence how the disease behaves. Research into genetic mutations continues to improve understanding of childhood kidney cancer and supports the development of more personalized approaches to care.

 

Genomic Medicine

Genomic medicine is the use of genetic and genomic information to guide healthcare decisions. In pediatric oncology, genomic medicine may help identify inherited cancer predisposition syndromes, improve diagnosis, and support personalized treatment planning. As research advances, genomic medicine is expected to play an increasingly important role in childhood cancer care.

 

Immunotherapy

Immunotherapy is a treatment approach that uses the body's immune system to recognize and attack cancer cells. While immunotherapy is not currently a standard treatment for most Wilms tumor patients, ongoing research is exploring its potential role in managing recurrent, high-risk, or treatment-resistant disease. Immunotherapy remains one of the most promising areas of modern cancer research.

 

International Research Collaboration

International research collaboration involves scientists, clinicians, healthcare institutions, and organizations working together across national borders to advance medical knowledge. Collaboration is particularly important in rare diseases such as Wilms tumor because it allows researchers to pool expertise, share data, and conduct larger studies that improve understanding and treatment outcomes.

 

Knowledge Translation

Knowledge translation is the process of converting research findings into practical healthcare improvements. Effective knowledge translation ensures that scientific discoveries are shared with healthcare professionals, policymakers, patients, and families so they can benefit from the latest evidence and advances in care.

 

Liquid Biopsy

A liquid biopsy is an emerging diagnostic technology that uses blood or other bodily fluids to detect cancer-related genetic material. Unlike traditional biopsies, liquid biopsies do not require tissue removal. Researchers are exploring whether liquid biopsy technologies may eventually help diagnose, monitor, and detect recurrence in childhood cancers such as Wilms tumor.

 

Machine Learning

Machine learning is a branch of artificial intelligence that enables computers to identify patterns and learn from data. In oncology, machine learning may be used to analyze imaging studies, predict treatment outcomes, identify risk factors, and support clinical decision-making. Research in this field continues to expand rapidly.

 

Molecular Profiling

Molecular profiling involves analyzing the genetic and molecular characteristics of a tumor. By identifying specific biological features, molecular profiling can help researchers better understand tumor behavior and may eventually support more personalized treatment approaches. Molecular research is becoming an increasingly important area of pediatric oncology.

 

Molecular Target

A molecular target is a specific protein, gene, receptor, or biological pathway that can be targeted by a therapy. Identifying molecular targets is a key step in the development of targeted therapies designed to attack cancer cells while minimizing damage to healthy tissues.

 

Personalized Medicine

Personalized medicine is an approach to healthcare that tailors treatment according to the individual characteristics of a patient and their disease. Factors such as genetics, tumor biology, treatment response, and health history may be considered when developing personalized treatment plans. Personalized medicine represents an important direction for the future of pediatric oncology.

 

Precision Oncology

Precision oncology is a specialized form of personalized medicine focused on cancer treatment. Precision oncology uses genetic, molecular, and biological information to identify therapies that may be most effective for a specific patient. Ongoing research aims to expand the role of precision oncology in Wilms tumor care.

 

Prognostic Factor

A prognostic factor is a characteristic that helps predict the likely outcome of a disease. Examples include tumor stage, histology, treatment response, genetic findings, and the presence of metastases. Understanding prognostic factors helps healthcare teams estimate risk and guide treatment decisions.

 

Research Network

A research network is a group of organizations, researchers, hospitals, and institutions that collaborate to advance scientific knowledge. Research networks play a vital role in improving understanding of Wilms tumor, supporting clinical trials, and accelerating the development of new treatments and supportive care strategies.

 

Risk Stratification

Risk stratification is the process of classifying patients according to their likelihood of experiencing specific outcomes such as recurrence or treatment complications. Factors used in risk stratification may include tumor stage, histology, genetic findings, and treatment response. This process helps guide treatment intensity and follow-up planning.

 

Targeted Therapy

Targeted therapy refers to treatments designed to attack specific molecules, genes, or biological pathways involved in cancer growth. Unlike traditional chemotherapy, targeted therapies aim to focus on cancer-related mechanisms while reducing damage to healthy cells. Research into targeted therapies continues to expand in pediatric oncology.

 

Translational Research

Translational research focuses on converting laboratory discoveries into practical treatments, diagnostic tools, and healthcare improvements. Often described as moving research "from bench to bedside," translational research plays an important role in ensuring that scientific advances benefit children affected by Wilms tumor and other childhood cancers.

 

Tumor Biology

Tumor biology refers to the study of how cancer develops, grows, spreads, and responds to treatment. Understanding tumor biology helps researchers identify risk factors, discover new therapies, improve treatment strategies, and better predict patient outcomes. Advances in tumor biology continue to shape the future of pediatric oncology.

 

Tumor Sequencing

Tumor sequencing is the process of analyzing the genetic makeup of cancer cells. Sequencing technologies help researchers identify mutations, genetic abnormalities, and molecular characteristics that may influence treatment response and disease behavior. Tumor sequencing is becoming an increasingly valuable tool in cancer research and precision medicine.

 

Wilms Tumor Research

Wilms tumor research encompasses scientific studies focused on understanding childhood kidney cancer and improving patient outcomes. Research areas include genetics, molecular biology, new therapies, survivorship, psychosocial care, global health, and healthcare delivery. Continued research remains essential for advancing treatment and improving the lives of children affected by Wilms tumor.